Cargando…
Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOACs) Study
BACKGROUND: The optimal timing to administer non–vitamin K oral anticoagulants (NOACs) in patients with acute ischemic stroke and atrial fibrillation is unclear. This prospective observational multicenter study evaluated the rates of early recurrence and major bleeding (within 90 days) and their tim...
Ejemplares similares
-
Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes
por: Paciaroni, Maurizio, et al.
Publicado: (2018) -
Response: Aortic Stiffness in Patients with Deep and Lobar Intracerebral Hemorrhage: Role of Antihypertensive Drugs and Statins
por: Acampa, Maurizio, et al.
Publicado: (2015) -
Sex-related differences in risk factors, type of treatment received
and outcomes in patients with atrial fibrillation and acute stroke: Results from
the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute
Ischemic Stroke and Atrial Fibrillation)
por: Antonenko, Kateryna, et al.
Publicado: (2017) -
Ischemic Stroke after Heart Transplantation
por: Acampa, Maurizio, et al.
Publicado: (2016) -
A Diagnostic Model to Predict SARS-CoV-2 Positivity in Emergency Department Using Routine Admission Hematological Parameters
por: Soloperto, Rossana, et al.
Publicado: (2021)